Correction to: Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative

Affiliations

• ¹ Pharmacovigilance and Patient Safety, AbbVie Inc., North Chicago, IL, USA. eric.cohen@abbvie.com.
• ² Pharmacovigilance and Patient Safety, AbbVie Inc., North Chicago, IL, USA.
• ³ Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
• ⁴ Department of Medicine, IBIMA_Plataforma Bionand, University of Malaga, Malaga, Spain.
• ⁵ Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA.
• ⁶ Division of Gastroenterology, Georgetown University, Washington, D.C., USA.
• ⁷ Digestive Disease Research Center, Medical University of South Carolina, Charleston, SC, USA.
• ⁸ Pharmacovigilance, Gilead Sciences Inc., Foster City, CA, USA.
• ⁹ Pharmacovigilance and Patient Safety, AbbVie Inc., Ottawa, ON, Canada.
• ¹⁰ Translational Medicine, Bayer HealthCare Pharmaceuticals LLC, Whippany, NJ, USA.
• ¹¹ Global Patient Safety, Eli Lilly and Company, Indianapolis, IN, USA.
• ¹² Department of Pharmacology and Pediatrics, IBIMA_Plataforma Bionand, University of Malaga, Malaga, Spain.